Managers / Q3 2024 · view latest →
AYAL Capital Advisors Ltd
CIK 0002011524 · 151 YONGE STREET, SUITE 1900, TORONTO, A6, M5C 2W7 · 416-687-6671
Summary
Ayal Capital Advisors Ltd reported $293M in U.S.-listed holdings across 33 positions for Q3 2024.
Its largest position, MDU, represents 6.2% of the portfolio.
Compared with Q2 2024, the fund opened 14 new positions and exited 13.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 55.8% · $164M
- ETP · 37.5% · $110M
- Other · 5.7% · $17M
- ADR · 1.0% · $3M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| B7SBROOKDALE SR LIVING INC | NEW | +1.20M | 1.20M | +$8M | $8M |
| IIIVI3 VERTICALS INC | NEW | +371.9K | 371.9K | +$8M | $8M |
| GPKGRAPHIC PACKAGING HLDG CO | NEW | +260.1K | 260.1K | +$8M | $8M |
| ASTLALGOMA STL GROUP INC | NEW | +612.5K | 612.5K | +$6M | $6M |
| DCBODOCEBO INC | NEW | +141.6K | 141.6K | +$6M | $6M |
| BCEBCE INC | NEW | +175.0K | 175.0K | +$6M | $6M |
| ARDTARDENT HEALTH PARTNERS INC | NEW | +313.6K | 313.6K | +$6M | $6M |
| TACTRANSALTA CORP | NEW | +452.3K | 452.3K | +$5M | $5M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $369M | 56 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $287M | 42 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $254M | 42 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $419M | 52 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $303M | 43 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $390M | 43 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $293M | 33 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $263M | 31 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $227M | 34 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $239M | 36 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.